Qiagen gets good news from FDA; Monteris names Schellhorn as new president, CEO;

@FierceMedDev: Brainsway in breakthrough for depression treatment - Globes. Report  | Follow @FierceMedDev

> The FDA has cleared Qiagen's ($QGEN) real-time polymerase chain reaction instrument Rotor-Gene Q MDx and a compatible test for the detection of influenza A/B. Qiagen release

> Monteris Medical has tapped John Schellhorn as president and CEO, succeeding the retiring James Duncan. Schellhorn will shepherd the continued development of the NeuroBlate system for the treatment of brain tumors. Monteris release

> Lifeline Scientific has received approval from Brazil's Agência Nacional de Vigilância Sanitária to market its full line of clinical transplantation products, including the LifePort kidney transporter. Lifeline release

> Agnivesh Agarwal has snapped up a 60 percent stake in Chennai, India-based Primex Healthcare, a medical diagnostics chain. Report

> MicroPhage has received an additional FDA 510(k) clearance expanding the market for its KeyPath MRSA/MSSA blood culture Test-BT. MicroPhage release

Biotech News

 @FierceBiotech: UCLA morphs stem cells into T-cell missiles that seek out and destroy HIV. Story | Follow @FierceBiotech

 @JohnCFierce: Note to China: Gotta watch out for those chromium-laced drug capsules. More | Follow @JohnCFierce

 @RyanMFierce: David Steinberg sheds light on where the open access movement could lead us: Scientific Hive Mind. Piece | Follow @RyanMFierce

> Tech visionary Thiel sets out to spark a biotech revolution. News

> Ono's oral MS drug eliminates brain lesions in promising Phase II study. Story

> Third Rock, biotech VCs make baby formula gambit. Article

Pharma News

@FiercePharma: Glaxo CFO Simon Dingemans tells IBD about "in-sourcing" previously farmed-out manufacturing (and more). Article | Follow @FiercePharma

> Supreme Court zeroes in on pharma reps' OT claims. Article

> Chinese regulators freeze sales of drugs with toxic capsules. Story

Pharma Manufacturing News

> South Africa creates list of drugs it will buy only if they are made there. News

> Samsung says its manufacturing 'DNA' will provide big biosimilar savings. Article

Biotech Research News

> Injected protein clumps trigger Parkinson's progression in mice. Story

> Mayo team spies new class of breast cancer mutation. Article

And Finally... More than 200 scientists worldwide collaborated on mapping the human genes of more than 20,000 people, and the study found that the HMGA2 gene may explain individual differences in brain size and intelligence. Item

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.